AMP conducts study on Genetic Test Registry Today, the Association for Molecular Pathology submitted written comments in response to the Request for Information made by the National Institutes of Health because of its Genetic Test Registry . AMP conducted a survey of its membership to formulate a thorough response to the RFI www.tadacipla.com . ‘With almost all respondents employed in a clinical laboratory setting, AMP will be able to inform the NIH on the overall a reaction to the GTR, including insight to the community’s worries and guidance to guarantee the GTR is normally a valued source,’ stated Dr. Karen Mann, President of AMP. AMP members reported the next reasons for taking part in a voluntary registry: to supply a reference for clinicians and the general public about what tests can be found, to increase transparency of tests, to supply a resource for health care professionals, to streamline screening, to boost data sharing, also to standardize tests.
AMP’s four-day time event on the latest developments in clinical molecular diagnostics The Association for Molecular Pathology invites the media to follow its upcoming 2009 Annual Conference and Exhibits and find out about the latest advances in clinical molecular diagnostics. What: The four-day time event will feature a lot more than 100 corporate exhibits, and also many cutting-edge lectures, workshops and plenary sessions. The keynote speaker may be the distinguished recipient of this year’s 2009 AMP Award for Excellence in Molecular Diagnostics, Kay E. Davies, Ph.D., of the University of Oxford. Additional display titles include: Related StoriesConfocal microscope designed designed for scientists released by Caliber IDNew study from TSRI and Salk factors to cause of debilitating nerve diseaseOJ Bio at Medica 2015 – Stage of Care diagnostics' function in reducing antibiotics prescribingGene Patents: Current Environment Response of Molecular Diagnostic Laboratories to Novel Influenza A Virus Infections Genetics of Complicated Pediatric Disorders: What Have We Learned The Malignancy Genome Atlas Mutation Analysis in Leukemias Who: AMP is offering complimentary registration packages for contacts from certified printing, online and broadcast news media outlets.